Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3

An important drawback in the management of glioblastoma (GBM) patients is the frequent relapse upon surgery and therapy. A likely explanation is that conventional therapies poorly affect a small population of stem-like cancer cells (glioblastoma stem cells, GSCs) that remain capable of repopulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Carla Lucia, Nuzzo, Silvia, Ibba, Maria Luigia, Ricci-Vitiani, Lucia, Pallini, Roberto, Condorelli, Gerolama, Catuogno, Silvia, de Franciscis, Vittorio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352497/
https://www.ncbi.nlm.nih.gov/pubmed/32486489
http://dx.doi.org/10.3390/cancers12061434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352497/
https://www.ncbi.nlm.nih.gov/pubmed/32486489
http://dx.doi.org/10.3390/cancers12061434

Ejemplares similares